Proteome Sciences plc

Equities

PRM

GB0003104196

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. Other stock markets 11:35:28 2024-04-26 am EDT			5-day change	1st Jan Change
4.15 ^GBX	+18.23%		+25.76%	-8.39%

12:39pm	Proteome Sciences Wins GBP500,000 Spectrometry Services Contract in US	MT
12:20pm	Proteome wins GBP500,000 deal to supply mass spectrometry services	AN

Proteome Sciences : to present Innovative Approaches & Novel Data for Alzheimer’s Disease at Upcoming AAIC

July 11, 2014 at 11:25 am EDT

11th July, 2014

Proteome Sciences plc will present data during multiple poster and oral sessions at the upcoming Alzheimer's Association International Conference® 2014 (AAIC® ) taking place in Copenhagen, Denmark from 12-17 July, 2014.

"Following the breakthrough publication on 8th July in Alzheimer's and Dementia Journal, that shows a 10-protein panel in blood that predicts the progression from MCI to Alzheimer's disease with 87% accuracy, we will be presenting a number of ground breaking developments at the meeting.

This will include the latest data on our proprietary CK1D inhibitor compounds (PS110 and PS278-05) showing prevention of tau-mediated damage by the CK1D compounds through modulation of key pathways relating to energy production, amyloid processing and oxidative phosphorylation. Read More.

distributed by

Latest news about Proteome Sciences plc

Proteome Sciences Wins GBP500,000 Spectrometry Services Contract in US	06:39am	MT
Proteome wins GBP500,000 deal to supply mass spectrometry services	06:20am	AN
AIM WINNERS & LOSERS: Proteome Sciences rises on GBP500,000 contract	05:42am	AN
Thoma Bravo snaps up Darktrace for USD5 billion	04:16am	AN
Proteome Sciences plc Secures Contract from US Biopharmaceutical Company	02:00am	CI
Proteome Sciences shares drop as revenue plunges and swings to loss	Apr. 10	AN
Proteome Sciences plc Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 10	CI
Proteome Sciences Completes New US Lab Setup	Jan. 02	MT
Proteome Sciences Announces the Completion of Installation and Setup of Equipment in Its New US Laboratory in San Diego, California	Jan. 02	CI
Proteome Sciences says San Diego lab now fully operational	Jan. 02	AN
AIM WINNERS & LOSERS: Totally slides again; Proteome warns on earnings	Nov. 30	AN
Proteome Sciences shares drop as cuts annual revenue outlook	Nov. 30	AN
Proteome Sciences sees shares surge on SysQuant service launch	23-10-02	AN
Proteome Sciences plc Announces the Launch of Sysquant® SCP, the Commercial Service for Single Cell Proteomics Using the Power of its TMTpro? Isobaric Labelling Reagents	23-10-02	CI
FTSE 100 Finishes Flat After Choppy Week	23-08-25	DJ
UK 2063 Gilt Seen Attractively Valued Ahead of Syndicated Tap	23-08-25	DJ
FTSE 100 pushes higher ahead of Fed chair speech	23-08-25	AN
AIM WINNERS & LOSERS: Panthera Resources secures litigation financing	23-08-25	AN
Proteome Sciences shares fall as swings to interim loss on costs	23-08-25	AN
Earnings Flash (PRM.L) PROTEOME SCIENCES Posts H1 Loss GBX-0.20	23-08-25	MT
Proteome Sciences plc Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25	CI
OnTheMarket new CFO Tom Carter starts role	23-07-04	AN
Proteome Sciences repays GBP824,400 loan in full to Vulpes	23-06-01	AN
Brand Architekts CFO to Step Down in June; Successor Named	23-05-26	MT
FTSE 100 Closes Down 0.35% After Corporate Updates; Melrose Industries Shines on Guidance Lift	23-05-17	DJ

Chart Proteome Sciences plc

Duration

Period

More charts

Company Profile

Proteome Sciences plc is a specialist provider of contract proteomics services. The services enable drug discovery, development, and biomarker identification and employ workflows for the optimum analysis of tissues, cells, and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic, and therapeutic applications. SysQuant and TMT MS2 are its unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using super-depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents, which are sold for multiplex quantitative proteomics.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-07-24 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
PROTEOME SCIENCES PLC	-8.39%	12.95M
ABBOTT LABORATORIES	-2.17%	185B
MEDTRONIC PLC	-3.19%	105B
BECTON, DICKINSON AND COMPANY	-4.47%	66.59B
DEXCOM, INC.	+1.58%	54.66B
CENCORA, INC.	+17.28%	47.78B
HOYA CORPORATION	+4.06%	41.26B
WEST PHARMACEUTICAL SERVICES, INC.	+3.01%	26.95B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.20%	26.37B
TERUMO CORPORATION	+12.96%	24.8B

Other Medical Equipment, Supplies & Distribution